Role of β-endorphin on phospholipase production in Malassezia pachydermatis in dogs: new insights into the pathogenesis of this yeast

References

• Guillot J, Bond R. Malassezia pachydermatis: a review. Med Mycol 1999; 4: 72–73
   Google Scholar
• Guého E, Midgley G, Guillot J. The genus Malassezia with description of four new species. Antonie van Leeuwenhoek 1996; 69: 335–337
   Web of Science ®Google Scholar
• Guillot J, Chermette R, Guého E. Prevalénce du genre Malassezia chez les Mammifères. J Mycol Med 1994; 4: 72–79
   Google Scholar
• Simmons RB, Guèho E. A new species of Malassezia. Mycol 1990; 94: 1146–1149
   Google Scholar
• Sugita T, Takashima M, Kodama M, Tsuboi R, Nishikawa A. Description of a new yeast species, Malassezia japonica and its detection in patients with atopic dermatitis and healthy subjects. J Clin Microbiol 2003; 41: 4695–4699
   PubMed Web of Science ®Google Scholar
• Sugita T, Takashima M, Shinoda T, et al. New yeast species, Malassezia dermatis, isolated from patients with atopic dermatitis. J Clin Microbiol 2002; 40: 1363–1367
   PubMed Web of Science ®Google Scholar
• Chen TA, Hill PB. The biology of Malassezia organisms and their ability to induce immune responses and skin disease. Vet Dermatol 2005; 16: 4–26
   PubMed Web of Science ®Google Scholar
• Bond R, Lloyd D H. Skin and mucosal populations of Malassezia pachydermatis in healthy and seborrhoeic Basset hound. Vet Dermatol 1997; 8: 101–106
   PubMed Web of Science ®Google Scholar
• Cafarchia C, Gallo S, Romito D, et al. Frequency, body distribution and population size of Malassezia yeasts in healthy dogs and in dogs with localized cutaneous lesions. J Vet Diagn Invest 2005; 17: 316–322
   PubMed Web of Science ®Google Scholar
• Cafarchia C, Gallo S, Capelli G, Otranto D. Occurrence and population size of Malassezia spp. in the external ear canal of dogs and cats both healthy and with otitis. Mycopathologia 2005; 160: 143–149
   PubMed Web of Science ®Google Scholar
• Cafarchia C, Otranto D. Association between phospholipase production by Malassezia pachydermatis and skin lesions. J Clin Microbiol 2004; 42: 4868–4869
   PubMed Web of Science ®Google Scholar
• Pranab KM, Mahmound AG. Secretory protein in fungal virulence. In: Calderone Richard A, Cihlar Ronald L (ed.), Fungal Pathogenesis: Principle and Clinical Applications, 10th ed. Washington, DC: Marcel Dekker Inc., 2002: 51–80.
   Google Scholar
• Barret-Bee K, Hayes KY, Wilson RG, Ryley JF. A comparison of phospholipase activity, cellular adherence and pathogenicity of yeasts. J Gen Microbiol 1985; 131: 1217–1222
   PubMedGoogle Scholar
• Hanel H, Menzel I, Holzman H. High phospholipase A activity of Candida albicans isolated from intestine psoriatic patients. Mycoses 1988; 31: 451–453
   PubMed Web of Science ®Google Scholar
• Price MF, Wilkinson ID, Gentry LO. Plate method for detection of phospholipase activity of Candida albicans. Sabouraudia 1982; 20: 7–14
   PubMedGoogle Scholar
• Ibrahim AS, Mirbod F, Filler SG, et al. Evidence implicating phospholipase as a virulence factor of Candida albicans. Infect Immun 1965; 63: 1993–1998
   Web of Science ®Google Scholar
• Mayser P, Laabs S, Heuer KV, Grunder K. Detection of extracellular phospholiphase activity in Candida albicans and Rhodotorula rubra. Mycopathologia 1996; 135: 149–155
   PubMed Web of Science ®Google Scholar
• Chen SC, Muller M., Zhou JZ, Wright LC, Sorrell TC. Phospholipase activity in Cryptococcus neoformans: a new virulence factor?. Infect Dis 1997; 175: 414–420
   Web of Science ®Google Scholar
• Slominski A. Beta-endorphin/mu-opiate receptor system in the skin. J Invest Dermatol 2003; 120: 1073–1080
   PubMed Web of Science ®Google Scholar
• Slominski A. Neuroendocrine system of the skin. Dermatology 2005; 211: 199–208
   PubMed Web of Science ®Google Scholar
• Way WL, Fields HL, Leong WE. Analgesici oppioidi e loro antagonisti. Farmacologia Generale e Clinica, BG Katzung. Piccin Nuova Libreria, Padova 2000; 527–546
   Google Scholar
• Corbett A, McKnight S, Anderson G. Opioid receptors. Tocris Cookson Pharmacological Review. Available from: www. tocris.com.
   Google Scholar
• Pan YX. Diversity and complexity of the mu opioid receptor gene: alternative pre-mRNA splicing and promoters. DNA Cell Biol 2005; 24: 736–750
   PubMed Web of Science ®Google Scholar
• Pasternak GW. Multiple opiate receptors: deja vu all over again. Neuropharmacology 2004; 47: 312–323
   PubMed Web of Science ®Google Scholar
• Bigliardi PL, Bigliardi-Qi M, Buechner S, Rufli T. Expression of µ-opiate receptor in human epidermis and keratinocytes. J Invest Dermatol 1998; 111: 297–301
   PubMed Web of Science ®Google Scholar
• Bigliardi-Qi M., Bigliardi PL, Eberle AN, Buchner S, Rufli T. Beta-endorphin stimulates cytokeratin 16 expression and downregulates mu-opiate receptor expression in human epidermis. J Invest Dermatol 2000; 114: 527–532
   PubMed Web of Science ®Google Scholar
• Bigliardi-Qi M, Sumanovski LT, Buchner S, Rufli T, Bigliardi PL. Mu-opiate receptor and Beta-endorphin expression in nerve endings and keratinocytes in human skin. Dermatology 2004; 209: 183–189
   PubMed Web of Science ®Google Scholar
• Bigliardi-Qi M., Lipp B, Sumanovski L T, Buechner SA, Bigliardi PL. Changes of epidermal mu-opiate receptor expression and nerve endings in chronic atopic dermatitis. Dermatology 2005; 210: 91–99
   PubMed Web of Science ®Google Scholar
• Georgala S, Schulpis KH, Papaconstantinou ED, Stratigos J. Raised beta-endorphin serum levels in children with atopic dermatitis and pruritus. J Dermatol Sci 1994; 8: 125–128
   PubMedGoogle Scholar
• Glinski W, Brodecka H, Glinska-Ferenz M, Kowalski D. Increased concentration of beta-endorphin in sera of patients with psoriasis and other inflammatory dermatoses. Br J Dermatol 1994; 131: 260–264
   PubMed Web of Science ®Google Scholar
• Glinski W, Brodecka H, Glinska-Ferenz M, Kowalski D. Neuropeptides in psoriasis: possible role of beta-endorphin in the pathomechanism of the disease. Int J Dermatol 1994; 33: 356–360
   PubMed Web of Science ®Google Scholar
• Dell'Aquila ME, Casavola V, Reshkin SJ, et al. Effects of beta-endorphin and Naloxone on in vitro maturation of bovine oocytes. Mol Reprod Dev 2002; 63: 210–222
   PubMed Web of Science ®Google Scholar
• Di Sole F, Guerra L, Bagorda A, et al. Naloxone inhibits A6 cell Na(+)/H(+) exchange by activating protein kinase C via the mobilization of intracellular calcium. Exp Nephrol 2001; 9: 341–348
   PubMedGoogle Scholar
• Witkin SS, Kalo-Klein A. Enhancement of germ tube formation in Candida albicans by beta-endorphin. Am J Obstet Gynecol 1991; 164: 917–920
   PubMed Web of Science ®Google Scholar